Long-term efficacy of rimonabant in improving glucose tolerance in overweight/obese non-diabetic patients: 2-year results from RIO-Europe

被引：0
作者：
Scheen, Andre J.
Van Gaal, Luc
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A31 / A31
页数：1
相关论文
共 50 条
[41]   LONG-TERM SAFETY AND EFFICACY OF SER120 1.5 MCG IN PATIENTS WITH NOCTURIA: RESULTS FROM A 2-YEAR OPEN-LABEL EXTENSION STUDY [J].
MacDiarmid, Scott ;
Nicandro, J. P. ;
Cheng, Maria ;
Abrams, Steven ;
Fein, Seymour ;
Wein, Alan .
JOURNAL OF UROLOGY, 2017, 197 (04) :E398-E398
[42]   Long-term effects of water-soluble corn bran hemicellulose on glucose tolerance in obese and non-obese patients: Improved insulin sensitivity and glucose metabolism in obese subjects [J].
Hanai, H ;
Ikuma, M ;
Sato, Y ;
Iida, T ;
Hosoda, Y ;
Matsushita, I ;
Nogaki, A ;
Yamada, M ;
Kaneko, E .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1997, 61 (08) :1358-1361
[43]   LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC THERAPIES: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 2 STUDY [J].
Mease, P. J. ;
Setty, A. ;
Papp, K. ;
Van den Bosch, F. ;
Tsuji, S. ;
Keiserman, M. ;
Bu, X. ;
Chen, L. ;
Mccaskill, R. ;
Mcdearmon-Blondell, E. ;
Wung, P. ;
Tillett, W. .
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 :836-837
[44]   LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC THERAPIES: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 2 STUDY [J].
Mease, Philip J. ;
Setty, Arathi ;
Papp, Kim ;
Van den Bosch, Filip ;
Tsuji, Shigeyoshi ;
Keiserman, Mauro ;
Bu, Xianwei ;
Chen, Liang ;
Mccaskill, Reva ;
Mcdearmon-Blondell, Erin ;
Wung, Peter ;
Tillett, William .
RHEUMATOLOGY, 2023, 62
[45]   Efficacy, tolerability and safety of long-term darifenacin treatment in older patients with overactive bladder: Analysis of results from a 2-year, open-label extension study [J].
Dwyer, P. ;
Lheritier, K. ;
Steel, M. .
NEUROUROLOGY AND URODYNAMICS, 2006, 25 (06) :657-658
[46]   LONG-TERM EVALUATION OF PENICILLAMINE OR CYCLOFENIL IN SYSTEMIC-SCLEROSIS - RESULTS FROM A 2-YEAR RANDOMIZED STUDY [J].
AKESSON, A ;
BLOMBULOW, B ;
SCHEJA, A ;
WOLLMER, P ;
VALIND, S ;
WOLLHEIM, FA .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1992, 21 (05) :238-244
[47]   Long-term benefits of darifenacin treatment for patient quality of life: Results from a 2-year extension study [J].
Dwyer, Peter ;
Kelleher, Con ;
Young, Jay ;
Haab, Francois ;
Lheritier, Karine ;
Ariely, Rinat ;
Ebinger, Ursula .
NEUROUROLOGY AND URODYNAMICS, 2008, 27 (06) :540-547
[48]   Pharmacokinetics and Immunogenicity of Maintenance Therapy With Ustekinumab: 2-Year Results From the UNIFI Long-Term Extension Study [J].
Adedokun, Omoniyi ;
Panaccione, Remo ;
Hisamatsu, Tadakazu ;
Abreu, Maria T. ;
Leong, Rupert W. L. ;
Rowbotham, David ;
Marano, Colleen ;
Zhou, Yiying ;
Zhang, Hongyan ;
Danese, Silvio ;
Afif, Waqqas ;
Peyrin-Biroulet, Laurent ;
Sandborn, William J. ;
Sands, Bruce E. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 :S437-S437
[49]   Long-term efficacy and safety of adalimumab in the treatment of active ankylosing spondylitis: Results of an open-label, 2-year trial [J].
Haibel, H. ;
Brandt, H. C. ;
Baraliakos, X. ;
Rudwaleit, M. ;
Listing, J. ;
Braun, J. ;
Kupper, H. ;
Sieper, J. .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 :218-219
[50]   EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS OF A 2-YEAR, OPEN-LABEL EXTENSION STUDY [J].
Correll, C. ;
Goldman, R. ;
Tocco, M. ;
Pikalov, A. ;
Deng, L. ;
Loebel, A. ;
Coghill, D. .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 :105-105
12345